Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel in connection with the investment in Sanviva
Mandate

Vinge advises Axcel in connection with the investment in Sanviva

June 03, 2026 M&A Corporate Commercial FDI

Vinge has advised the Nordic private equity firm Axcel in connection with the establishment of Sanviva, a new European medical device distribution network.

Sanviva brings together medical device distributors Apodan, PartnerMed, AllweCare and XboXLab, operating across the Nordics and Benelux with a portfolio covering product categories such as wound care, ostomy care and in vitro diagnostics. Sanviva currently employs around 60 people across Denmark, Sweden, Norway, Finland, Belgium and the Netherlands.

The investment in Sanviva was made through Axcel Elevate I, Axcel’s lower mid-market fund focused on technology, business services and healthcare.

Vinge’s team consisted of Christina Kokko, Egil Svensson, Ida Appelgren, Manon de Cooman and Lina Björkman (M&A), Christoffer Nordin (Corporate Commercial), Dagne Sabockis and Julia Rydin (FDI) and Filippa Bergkvist (Transaction Support Coordinator).

Read the client’s press release. 

Related

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson

Vinge has advised Accent Equity VI and the minority shareholders on their divestment of Malte Månson to Citira, a European tire management provider and portfolio company of Norvestor. Headquartered in Stockholm, Malte Månson is an independent service and repair provider for commercial vehicles and operates a network of 28 service workshop locations across Sweden, authorized by brands such as MAN, DAF, IVECO, Mercedes-Benz, Setra, VDL and EVO. Malte Månson has an annual revenue of SEK 800 million and employs over 300 full-time professionals.
June 08, 2026

Vinge advises InArea on entering into a SEK 450 million credit agreement with SEB

 InArea's new facilities agreement comprises a term loan and a revolving credit facility, replacing the company's existing facilities. The facilities agreement also includes an option to increase the lending framework through an incremental facility of up to SEK 200 million.
June 03, 2026

Vinge has advised the arrangers in connection with St1 Biokraft’s EUR 260 million financing

 Vinge has advised the arrangers, ING Bank N.V., ABN AMRO Bank N.V., DNB Bank ASA, Nordea Bank Abp, OP Corporate Bank plc, Coöperatieve Rabobank U.A., SpareBank 1 Sør-Norge ASA and Swedbank AB, in connection with St1 Biokraft AB’s EUR 260 million financing.
June 03, 2026